AEON Biopharma Inc (AEON) concluded trading on Thursday at a closing price of $0.14, with 6.37 million shares of worth about $0.89 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -84.84% during that period and on February 06, 2025 the price saw a gain of about 16.18%. Currently the company’s common shares owned by public are about 79.97M shares, out of which, 47.52M shares are available for trading.
Stock saw a price change of 15.23% in past 5 days and over the past one month there was a price change of -33.33%. Year-to-date (YTD), AEON shares are showing a performance of -74.07% which decreased to -98.49% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.10 but also hit the highest price of $17.17 during that period. The average intraday trading volume for AEON Biopharma Inc shares is 16.38 million. The stock is currently trading 2.22% above its 20-day simple moving average (SMA20), while that difference is down -65.76% for SMA50 and it goes to -87.82% lower than SMA200.
AEON Biopharma Inc (AMEX: AEON) currently have 79.97M outstanding shares and institutions hold larger chunk of about 26.23% of that.
The stock has a current market capitalization of $11.20M and its 3Y-monthly beta is at 0.05. It has posted earnings per share of -$0.24 in the same period. It has Quick Ratio of 0.22. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for AEON, volatility over the week remained 11.00% while standing at 19.02% over the month.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by H.C. Wainwright on August 18, 2023 offering a Buy rating for the stock and assigned a target price of $18 to it.
